Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--#AMD--Character Biosciences, a precision medicine company ...

“2024 was a transformational year for Precision BioSciences as we solidified ourselves as a leading in vivo gene editing company, and we now have clinical data from two differentiated ARCUS based ...

Sev­en years in­to its ex­is­tence, Char­ac­ter Bio­sciences is ready to en­ter the clin­ic with a pair of ex­per­i­men­tal med­i­cines tar­get­ing a bustling area of oph­thal ...

Character Biosciences has landed a $93 million series B to progress its precision medicine candidates through clinical development. The round was led by new investors aMoon and Luma Group ...

BOSTON, Mass., March 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve ...

Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug application by the U.S. FDA for first-in ...

AstraZeneca is bolstering its cell therapy capabilities, agreeing on Monday to pay up to $1 billion for a biotechnology startup making treatments that reprogram cells inside the body. The British ...

SAN DIEGO--(BUSINESS WIRE)--Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell ...

Biosciences is a vibrant, research-led department with a focus on the science underpinning global challenges. We support a broad-based, sustainability-centred research strategy, informed by scientific ...